For the 2024 matriculation cycle, the AAMC Facts table B-8 indicates 740 matriculants as first-year. Table B-12 indicates 765. The final admission actions report for 2024 (closed cycle) indicated 781 matriculants while 860 applicants received at least one MD/PhD acceptance out of the 1,856 MD/PhD applicants. Why they are different numbers? The most common reason is related to SOM Registrars not reporting properly in the AAMC Students Record System the student's MD/PhD status. This is part of the matriculation process.
Move-on to 2025, the AAMC Fact tables will be released around December 2025. The only data available is the admission actions report, so I will compare apples to apples. The current admission actions report (open cycle) for 2025 matriculation class entering their first-year of training shows 754 currently accepted with 800 applicants having received at least one MD/PhD acceptance out of 2,007 MD/PhD applicants. So, if we were to assume that this was the end of the cycle, for 2025,
it looks like just a 3.4% decrease (vs 2024) in the total number of MD/PhD slots, or less as the cycle still is open. We also need to see how many trainees actually matriculate. The only large MSTP that was reported to not take new students in 2025 was NYU (took 13 first-year trainees in 2024), which means that
the other 14 slots potentially not being offered this year are spread out over >100 other MD/PhD programs. This is within variation seen every year. The other issue is why we only needed 800 applicants to fill a class of 754, as compared to 860 applicants filling a class of 781. There are several factors that might be at play. Here are a few thoughts:
- There is a decrease of regular PhD opportunities (some science news outlets indicate ~ 25% less positions); that decrease might have impacted some well rounded applicants with a MD/PhD acceptance to stay MD/PhD rather than pursuing just PhD (this is a small group).
- Some prestigious medical schools with a MD only offer (maybe a promise to transfer in a later time) who some MD/PhD applicants with high numbers might have chosen in a regular cycle could have decreased the financial aid packages because margins are needed to shore the loss of research indirect costs. That left some of those candidates in mid-tier MD-PhD programs.
- Unfounded mass hysteria, programs and applicants behaved more conservatively this year due to financially difficult times.